|
|
Volumn 10, Issue 5, 2014, Pages 264-265
|
|
Dealing with increased vascular risk and mortality in GCA
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
GLUCOCORTICOID;
CARDIOVASCULAR RISK;
DISEASE ASSOCIATION;
DISEASE SEVERITY;
DOPPLER ECHOGRAPHY;
DRUG MEGADOSE;
GIANT CELL ARTERITIS;
HIGH RISK PATIENT;
HUMAN;
INCIDENCE;
INFLAMMATION;
MORTALITY;
NOTE;
PATIENT MONITORING;
PATIENT SAFETY;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
PROGNOSIS;
RISK ASSESSMENT;
VASCULAR DISEASE;
VASCULITIS;
AORTITIS;
ARTERY INTIMA PROLIFERATION;
CEREBROVASCULAR ACCIDENT;
CLAUDICATION;
DIABETES MELLITUS;
DRUG DOSE REDUCTION;
DRUG SAFETY;
DRUG SUBSTITUTION;
DRUG WITHDRAWAL;
DYSLIPIDEMIA;
HEALTH CARE QUALITY;
HEART INFARCTION;
HYPERTENSION;
INFLAMMATORY DISEASE;
OBESITY;
OPTIMAL DRUG DOSE;
OSTEOPOROSIS;
PATIENT CARE;
PERIPHERAL VASCULAR DISEASE;
RECURRENT DISEASE;
SERODIAGNOSIS;
SHORT SURVEY;
SKIN ATROPHY;
SURVIVAL RATE;
SWEDEN;
TREATMENT DURATION;
VISUAL IMPAIRMENT;
CARDIOVASCULAR DISEASES;
COMPLICATION;
SYNDROME;
CARDIOVASCULAR DISEASES;
GIANT CELL ARTERITIS;
HUMANS;
SYNDROME;
|
|
EID: 84899989030
PISSN: 17594790
EISSN: 17594804
Source Type: Journal
DOI: 10.1038/nrrheum.2014.38 Document Type: Note |
|
Times cited : (11)
|
|
References (10)
|
